Glenmede Trust’s Crinetics Pharmaceuticals CRNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $582K | Sell |
17,352
-38
| -0.2% | -$1.28K | ﹤0.01% | 858 |
|
|
2024
Q4 | $889K | Buy |
17,390
+246
| +1% | +$12.6K | ﹤0.01% | 758 |
|
|
2024
Q3 | $876K | Sell |
17,144
-807
| -4% | -$41.2K | ﹤0.01% | 756 |
|
|
2024
Q2 | $804K | Buy |
17,951
+11,013
| +159% | +$493K | ﹤0.01% | 751 |
|
|
2024
Q1 | $325K | Buy |
+6,938
| New | +$325K | ﹤0.01% | 1035 |
|
|
2023
Q4 | – | Sell |
-7,518
| Closed | -$224K | – | 1305 |
|
|
2023
Q3 | $224K | Buy |
+7,518
| New | +$224K | ﹤0.01% | 1073 |
|